Victoria L. Chiou, an oncologist at the National Cancer Institute ’s Women ’s Malignancies Department, reported a phase I trial at AACR2015. The results showed that olaparib combined with carbopla...
Cervical cancerAccording to the statistics of the World Health Organization in 2012, there are nearly 530,000 new cases of cervical cancer worldwide each year, and the annual death toll is 266,000. M...
Adolescent obesity is associated with many health problems in later life, and a large Israeli study has shown that the increased risk of fatal pancreatic cancer is one of them. For more than 20 y...
The survival rate of pancreatic cancer is very low. In the past 40 years, the survival rate has not changed significantly. Finding effective treatments is an urgent challenge for researchers. For man...
Specific molecular signals released by pancreatic cancer cells have been determined. Pancreatic cancer is usually detected after the disease has spread, and chemotherapy often has no effect on slowin...
In a recent interview, Dr. Afsaneh Barzi, assistant professor of clinical medicine at the University of Southern California Norris Comprehensive Cancer Center, told you about existing and emerging new...
New research has found that pancreatic cancer cells rely heavily on a protein to grow and spread. The research results can bring new treatment and prevention strategies for pancreatic cancer.The Amer...
A recent study published in the journal Cellular and Molecular Gastroenterology and Hepatology showed that a gene mutation called ATRX may lead to an increased risk of pancreatitis and pancreatic canc...
Dr. Thomas A. Steitz died on October 9, 2018 at the age of 78, and died of pancreatic cancer. Steitz is the co-winner of the 2009 Nobel Prize in Chemistry.Steitz's research on the ribosome has had a ...
Ruiwen Zhang and Robert L. Boblitt from the University of Houston have developed a new pancreatic cancer drug. The research was published in the Journal of Cancer Research. The drug targets two gene...